232 related articles for article (PubMed ID: 26148099)
1. Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
Leray E; Vukusic S; Debouverie M; Clanet M; Brochet B; de Sèze J; Zéphir H; Defer G; Lebrun-Frenay C; Moreau T; Clavelou P; Pelletier J; Berger E; Cabre P; Camdessanché JP; Kalson-Ray S; Confavreux C; Edan G
PLoS One; 2015; 10(7):e0132033. PubMed ID: 26148099
[TBL] [Abstract][Full Text] [Related]
2. An excessive risk of suicide may no longer be a reality for multiple sclerosis patients.
Kalson-Ray S; Edan G; Leray E;
Mult Scler; 2017 May; 23(6):864-871. PubMed ID: 28299961
[TBL] [Abstract][Full Text] [Related]
3. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
[TBL] [Abstract][Full Text] [Related]
4. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
Lunde HMB; Assmus J; Myhr KM; Bø L; Grytten N
J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):621-625. PubMed ID: 28365589
[TBL] [Abstract][Full Text] [Related]
5. Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort.
Rollot F; Fauvernier M; Uhry Z; Vukusic S; Bossard N; Remontet L; Leray E;
Neurology; 2021 Jul; 97(4):e403-e413. PubMed ID: 34011577
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of patients with multiple sclerosis in West France.
Leray E; Morrissey S; Yaouanq J; Coustans M; Le Page E; Chaperon J; Edan G
Mult Scler; 2007 Aug; 13(7):865-74. PubMed ID: 17881399
[TBL] [Abstract][Full Text] [Related]
7. [Survival in disseminated sclerosis in Denmark. A nation-wide study of the period 1948-1986].
Brønnum-Hansen H; Koch-Henriksen NJ; Hyllested K
Ugeskr Laeger; 1995 Dec; 157(51):7131-5. PubMed ID: 8545927
[TBL] [Abstract][Full Text] [Related]
8. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway.
Grytten Torkildsen N; Lie SA; Aarseth JH; Nyland H; Myhr KM
Mult Scler; 2008 Nov; 14(9):1191-8. PubMed ID: 18632781
[TBL] [Abstract][Full Text] [Related]
9. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients.
Smestad C; Sandvik L; Celius EG
Mult Scler; 2009 Nov; 15(11):1263-70. PubMed ID: 19812114
[TBL] [Abstract][Full Text] [Related]
10. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study.
Wilson S; Calocer F; Rollot F; Fauvernier M; Remontet L; Tron L; Vukusic S; Le Page E; Debouverie M; Ciron J; Ruet A; De Sèze J; Zephir H; Moreau T; Lebrun-Frénay C; Laplaud DA; Clavelou P; Labauge P; Berger E; Pelletier J; Heinzlef O; Thouvenot E; Camdessanché JP; Leray E; Dejardin O; Defer G
Lancet Reg Health Eur; 2023 Jan; 24():100542. PubMed ID: 36426377
[TBL] [Abstract][Full Text] [Related]
11. Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000-2001.
Yaouanq J; Tron I; Kerbrat A; Leray E; Hamonic S; Merienne M; Hinault P; Edan G
Acta Neurol Scand; 2015 May; 131(5):321-8. PubMed ID: 25313028
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey.
Brønnum-Hansen H; Koch-Henriksen N; Hyllested K
Neurology; 1994 Oct; 44(10):1901-7. PubMed ID: 7936244
[TBL] [Abstract][Full Text] [Related]
13. Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study.
Koch-Henriksen N; Laursen B; Stenager E; Magyari M
J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):626-631. PubMed ID: 28705951
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.
Foulon S; Maura G; Dalichampt M; Alla F; Debouverie M; Moreau T; Weill A
J Neurol; 2017 Jun; 264(6):1185-1192. PubMed ID: 28516332
[TBL] [Abstract][Full Text] [Related]
15. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis survival: a population-based study in Sicily.
Ragonese P; Aridon P; Mazzola MA; Callari G; Palmeri B; Famoso G; Terruso V; Salemi G; D'Amelio M; Savettieri G
Eur J Neurol; 2010 Mar; 17(3):391-7. PubMed ID: 19863646
[TBL] [Abstract][Full Text] [Related]
17. Causes of death among persons with multiple sclerosis.
Cutter GR; Zimmerman J; Salter AR; Knappertz V; Suarez G; Waterbor J; Howard VJ; Marrie RA
Mult Scler Relat Disord; 2015 Sep; 4(5):484-490. PubMed ID: 26346799
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France.
Debouverie M; Louis S; Pittion-Vouyovitch S; Roederer T; Vespignani H
J Neurol; 2007 Oct; 254(10):1370-5. PubMed ID: 17579804
[TBL] [Abstract][Full Text] [Related]
19. Disability progression in multiple sclerosis is slower than previously reported.
Tremlett H; Paty D; Devonshire V
Neurology; 2006 Jan; 66(2):172-7. PubMed ID: 16434648
[TBL] [Abstract][Full Text] [Related]
20. Trends in survival and cause of death in Danish patients with multiple sclerosis.
Brønnum-Hansen H; Koch-Henriksen N; Stenager E
Brain; 2004 Apr; 127(Pt 4):844-50. PubMed ID: 14960501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
